Introduction Intravenous (IV) ketamine has emerged as a powerful therapeutic intervention for individuals suffering from treatment-resistant mood disorders, chronic pain syndromes, and post-traumatic stress disorder (PTSD). Unlike traditional pharmacotherapies that often target monoaminergic systems and may take weeks to work, ketamine operates through a distinct mechanism of action on the glutamatergic system. Its ability to […]
